参考文献/References:
[1] WANG T,AZEDDINE B,MAH W,et al.Osteonecrosis of the femoral head:genetic basis[J].Int Orthop,2019,43(3):519-530.
[2] ZHAO D W,YU M,HU K,et al.Prevalence of nontraumatic osteonecrosis of the femoral head and its associated risk factors in the Chinese population:results from a nationally re-presentative survey[J].Chin Med J(Engl),2015,128(21):2843-2850.
[3] MONT M A,SALEM H S,PIUZZI N S,et al.Nontraumatic osteonecrosis of the femoral head:where do we stand today?:A 5-year update[J].J Bone Joint Surg Am,2020,102(12):1084-1099.
[4] MONT M A,ZYWIEL M G,MARKER D R,et al.The natural history of untreated of the femoral head:a systematic literature review[J].J Bone Joint Surg Am,2010,92(12):2165-2170.
[5] HUANG Z Q,FU F Y,LI W L,et al.Current treatment modalities for osteonecrosis of femoral head in mainland China:a cross-sectional study[J].Orthop Surg,2020,12(6):1776-1783.
[6] LI Z R,CHENG L M,WANG K Z,et al.Herbal Fufang Xian Ling Gu Bao prevents corticosteroid-induced osteonecrosis of the femoral head—a first multicentre,randomised,double-blind,placebo-controlled clinical trial[J].J Orthop Translat,2017,12:36-44.
[7] WEI Q S,HONG G J,YUAN Y J,et al.Huo Xue Tong Luo capsule,a vasoactive herbal formula prevents progression of asymptomatic osteonecrosis of femoral head:a prospective study[J].J Orthop Translat,2019,18:65-73.
[8] HUANG Z,FU F,YE H,et al.Chinese herbal Huo-Gu formula for the treatment of steroid-associated osteonecrosis of femoral head:a 14-year follow-up of convalescent SARS patients[J].J Orthop Translat,2020,23:122-131.
[9] MONT M A,MARULANDA G A,JONES L C,et al.Systematic analysis of classification systems for osteonecrosis of the femoral head[J].J Bone Joint Surg Am,2006,88(Suppl 3):16-26.
[10] 李子荣,刘朝晖,孙伟,等.基于三柱结构的股骨头坏死分型——中日友好医院分型[J].中华骨科杂志,2012,32(6):515-520.
[11] 郭效东,陈卫衡,赵永刚,等.股骨头无菌性坏死三期辨证论治的临床研究[J].中国骨伤,1995,8(6):19-20.
[12] 刘少军,袁浩.股骨头坏死的中医临床思路与方法探讨[J].中国医药学报,2002,17(1):44-47.
[13] 何伟.如何把握股骨头坏死患者的保髋治疗时机[J].中国骨与关节杂志,2016,5(2):82-86.
[14] ZHANG Q Y,LI Z R,GAO F Q,et al.Pericollapse stage of osteonecrosis of the femoral head:a last chance for joint preservation[J].Chin Med J(Engl),2018,131(21):2589-2598.
[15] 陈卫衡,刘道兵,张洪美,等.股骨头坏死的三期四型辨证思路[J].中国中医基础医学杂志,2003,9(12):51-52.
[16] 中华中医药学会.股骨头坏死中医辨证标准(2019年版)[J].中医正骨,2019,31(6):1-2.
[17] 郭蕾,王永炎,张志斌.关于证候概念的诠释[J].北京中医药大学学报,2003,26(2):5-8.
[18] 王旭东.辨证论治法则的历史观、辩证观[J].中国医药学报,1988,3(1):53-55.
[19] 赵文,林雪娟,周常恩,等.中医辨证的内涵与外延[J].中国中医基础医学杂志,2021,27(11):1689-1692.
[20] 原淳淳,王晶,舒冰,等.中医表型组学的概念与相关研究体系的构建[J].中医杂志,2022,63(5):407-411.
[21] 左玲,陈建新,王伟,等.中医信息学与表型组学:症状的遗传突变与证候的生物学基础初探[J].北京中医药大学学报,2022,45(2):140-147.
[22] 张彦琼,李梢.网络药理学与中医药现代研究的若干进展[J].中国药理学与毒理学杂志,2015,29(6):883-892.
[23] 许海玉,杨洪军.整合药理学:中药现代研究新模式[J].中国中药杂志,2014,39(3):357-362.
[24] 蔡甜甜,潘华峰,王奇,等.中药复方在病证基础上的网络药理学研究[J].中华中医药杂志,2016,31(11):4746-4748.
[25] 李梢,王永炎,季梁,等.复杂系统意义下的中医药学及其案例研究[J].系统仿真学报,2002,14(11):1429-1431.
[26] 李泰贤,张彦琼,薛志鹏,等.激素性股骨头坏死不同中医证候分型相关基因表达谱的鉴定及其候选标志分子的发现与验证[J].中华中医药杂志,2019,34(10):4536-4542.
[27] 李泰贤,张彦琼,黄泽青,等.从分子网络解析非创伤性股骨头坏死不同中医证候的生物学基础及其对证方药的作用机制[J].中国实验方剂学杂志,2020,26(16):192-204.
相似文献/References:
[1]陈雷雷,张颖.何伟教授采用中医药疗法治疗股骨头坏死的经验[J].中医正骨,2015,27(10):74.
[2]徐西林,赵永兰,张晓峰,等.活骨注射液髋关节腔灌注对兔股骨头坏死模型
血管内皮生长因子表达的动态影响[J].中医正骨,2015,27(08):1.
XU Xilin,ZHAO Yonglan,ZHANG Xiaofeng,et al.Dynamic effect of intra-articular hip injection of Huogu injection on the expression of vascular endothelial growth factor in rabbit models with femur head necrosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(03):1.
[3]周勇,任菲菲,丰凡翔,等.血管内皮生长因子和骨形态发生蛋白2
在非创伤性股骨头坏死不同区域的表达[J].中医正骨,2015,27(08):7.
ZHOU Yong,REN Feifei,FENG Fanxiang,et al.Expressions of vascular endothelial growth factor and bone morphogenetic protein 2 in different zones of femoral head with non-traumatic osteonecrosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(03):7.
[4]鲍荣华,王国平,夏晓斌,等.钽棒植入治疗非创伤性股骨头坏死的疗效观察[J].中医正骨,2015,27(02):28.
[5]张兵,马凰富,刘波,等.非创伤性股骨头坏死的舌象定量研究[J].中医正骨,2015,27(04):8.
ZHANG Bing,MA Huangfu,LIU Bo,et al.Quantitative study on tongue manifestation of patients with nontraumatic osteonecrosis of femoral head[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(03):8.
[6]李刚,程春生.股骨头坏死血瘀证症状与平乐郭氏正骨方药药物组成
最大频繁关联模式挖掘[J].中医正骨,2015,27(04):21.
LI Gang,CHENG Chunsheng.Maximal frequent association pattern mining for studying the relationship between BLOOD STASIS syndrome in patients with osteonecrosis of femoral head and drug components of Pingle Guo's orthopedics prescription[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(03):21.
[7]李文龙,梅沉成,杜贵强,等.微创减压植骨多孔钽棒植入治疗
ARCOⅡ期非创伤性缺血性股骨头坏死[J].中医正骨,2016,28(02):43.
[8]张磊,金红婷,童培建.骨健口服液早期干预非创伤性股骨头坏死的临床研究[J].中医正骨,2016,28(03):14.
ZHANG Lei,JIN Hongting,TONG Peijian.Clinical study on Gujian Koufuye(骨健口服液)for early intervention of nontraumatic osteonecrosis of femoral head[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(03):14.
[9]鲍荣华,王国平,夏晓斌,等.直接前入路微创全髋关节置换术治疗晚期股骨头坏死[J].中医正骨,2016,28(03):61.
[10]张超,姚晨,沈计荣.微创髓芯减压打压支撑植骨术结合补肾活血汤口服治疗ARCOⅡ、Ⅲ期股骨头坏死的近期疗效观察[J].中医正骨,2016,28(03):20.
ZHANG Chao,YAO Chen,SHEN Jirong.[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(03):20.
[11]张程,何海军.中医药防治股骨头坏死的优势与面临的挑战[J].中医正骨,2023,35(11):60.